France: Covalab secures government funding to increase production capacity


Covalab, a biotechnology company specializing in the development and production of recombinant proteins and antibodies for diagnostics and therapeutics, has been awarded €491,152 in funding for its BioDiaThera project. The financing forms part of the French ‘Capacity Building’ scheme; part of the ‘France 2030’ investment roadmap. Launched by the French government, this scheme is intended…

You must be a HMI Subscriber to view this content.

Subscribe Now »